FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-9162com.
(The FASEB Journal. 2008;22:365-373.)
© 2008 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.07-9162comv1
22/2/365    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Basting, D.
Right arrow Articles by Glaubitz, C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basting, D.
Right arrow Articles by Glaubitz, C.
(The FASEB Journal. 2008;22:365-373.)
© 2008 FASEB

Transport cycle intermediate in small multidrug resistance protein is revealed by substrate fluorescence

Daniel Basting1, Mark Lorch1,2, Ines Lehner and Clemens Glaubitz3

Institute for Biophysical Chemistry and Centre for Biomolecular Magnetic Resonance, J. W. Goethe University, Frankfurt, Germany

3Correspondence: Intitut für Biophysikalische Chemie, J. W. Goethe Universität, Max von Laue Str. 9, 60438 Frankfurt, Germany. E-mail: glaubitz{at}em.uni-frankfurt.de

Efflux pumps of the small multidrug resistance family bind cationic, lipophilic antibiotics and transport them across the membrane in exchange for protons. The transport cycle must involve various conformational states of the protein needed for substrate binding, translocation, and release. A fluorescent substrate will therefore experience a significant change of environment while being transported, which influences its fluorescence properties. Thus the substrate itself can report intermediate states that form during the transport cycle. We show the existence of such a substrate-transporter complex for the EmrE homolog Mycobacterium tuberculosis TBsmr and its substrate ethidium bromide. The pH gradient needed for antiport has been generated by co-reconstituting TBsmr with bacteriorhodopsin. Sample illumination generates a {Delta}pH, which results in enhanced ethidium fluorescence intensity, which is abolished when {Delta}pH or {Delta}{Psi} is collapsed or when the essential residue Glu-13 in TBsmr is exchanged with Ala. This observation shows the formation of a pH-dependent, transient substrate-protein complex between binding and release of ethidium. We have further characterized this state by determining the Kd, by inhibiting ethidium transport through titration with nonfluorescent substrate and by fluorescence anisotropy measurements. Our findings support a model with a single occluded intermediate state in which the substrate is highly immobile.—Basting, D., Lorch, M., Lehner, I., Glaubitz, C. Transport cycle intermediate in small multidrug resistance protein is revealed by substrate fluorescence.


Key Words: bacteriorhodopsin • EmrE • ethidium bromide • TBsmr




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
I. Lehner, D. Basting, B. Meyer, W. Haase, T. Manolikas, C. Kaiser, M. Karas, and C. Glaubitz
The Key Residue for Substrate Transport (Glu14) in the EmrE Dimer Is Asymmetric
J. Biol. Chem., February 8, 2008; 283(6): 3281 - 3288.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.